Showing results (31-40 of 85) with videos related to
Sort By:
Pageof 9
European Journal of Pharmacology|July 24, 2018
Evaluation and translation of combination therapies in oncology - A quantitative approachTim Cardilin, Joachim Almquist, Mats Jirstrand, et al.Frontiers in Psychiatry|June 6, 2022
Remission of Persistent Negative Symptoms and Psychosocial Consequences by Combined Clozapine and Cariprazine Treatment in a Patient With Long-Standing Treatment-Resistant Schizoaffective DisorderMats Bogren, Monica Soltesz, Stephan HjorthJournal of Pharmaceutical and Biomedical Analysis|June 1, 2005
Studies of drug binding to plasma proteins using a variant of equilibrium dialysisMats A L Eriksson, Johan Gabrielsson, Lars B NilssonJournal of Pharmacokinetics and Pharmacodynamics|October 12, 2013
Feedback modeling of non-esterified fatty acids in obese Zucker rats after nicotinic acid infusionsChristine Ahlström, Tobias Kroon, Lambertus A Peletier, et al.Journal of Pharmacokinetics and Pharmacodynamics|January 24, 2019
Modelling of oscillatory cortisol response in horses using a Bayesian population approach for evaluation of dexamethasone suppression test protocolsFelix Held, Carl Ekstrand, Marija Cvijovic, et al.The AAPS Journal|February 20, 2015
Mixed Effects Modeling Using Stochastic Differential Equations: Illustrated by Pharmacokinetic Data of Nicotinic Acid in Obese Zucker RatsJacob Leander, Joachim Almquist, Christine Ahlström, et al.Journal of Pharmacokinetics and Pharmacodynamics|February 20, 2019
Challenge model of TNFα turnover at varying LPS and drug provocationsFelix Held, Edmund Hoppe, Marija Cvijovic, et al.Journal of Pharmacological and Toxicological Methods|February 16, 2010
Optimising in vivo pharmacology studies--Practical PKPD considerationsJohan Gabrielsson, A Richard Green, Piet H Van der GraafJournal of Pharmacokinetics and Pharmacodynamics|November 4, 2010
Feedback modeling of non-esterified fatty acids in rats after nicotinic acid infusionsChristine Ahlström, Lambertus A Peletier, Rasmus Jansson-Löfmark, et al.Frontiers in Psychiatry|September 7, 2021
Case Report: Cariprazine in a Patient With Schizophrenia, Substance Abuse, and Cognitive DysfunctionJose Rodriguez Cruz, Johan Sahlsten Schölin, Stephan HjorthPageof 9